Hideya Kitamura
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 63
- Vasculitis and related conditions 3
-
- COVID-19 Clinical Research Studies 15
- Co-authors
- Takashi Ogura (77 shared papers)Tomohisa Baba (59 shared papers)Eri Hagiwara (43 shared papers)Tae Iwasawa (34 shared papers)Tamiko Takemura (32 shared papers)Akimasa Sekine (41 shared papers)Koji Okudela (25 shared papers)Satoshi Ikeda (34 shared papers)
- Journals
- BMC Pulmonary Medicine (8 papers)Scientific Reports (5 papers)Respirology (4 papers)Nature (4 papers)Respiration (3 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hideya Kitamura
103 papers receiving 3.2k citations
Hideya Kitamura's Hit Papers
Peers
Comparison fields: 5 of 105
- Pulmonary and Respiratory Medicine 1.5k
- Infectious Diseases 644
- Immunology and Allergy 72
- Genetics 417
- Pathology and Forensic Medicine 126
Countries citing papers authored by Hideya Kitamura
This map shows the geographic impact of Hideya Kitamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideya Kitamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideya Kitamura more than expected).
Fields of papers citing papers by Hideya Kitamura
This network shows the impact of papers produced by Hideya Kitamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideya Kitamura. The network helps show where Hideya Kitamura may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideya Kitamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Hit paper breakdown → | 2020 | 416 |
| 3 | 2011 | 162 | |
| 4 | 2014 | 122 | |
| 5 | 2019 | 109 | |
| 6 | 2013 | 89 | |
| 7 | 2019 | 89 | |
| 8 | 2021 | 88 | |
| 9 | 2014 | 80 | |
| 10 | 2016 | 69 | |
| 11 | 2022 | 69 | |
| 12 | 2019 | 64 | |
| 13 | 2023 | 60 | |
| 14 | 2017 | 55 | |
| 15 | 2009 | 51 | |
| 16 | 2020 | 51 | |
| 17 | 2021 | 49 | |
| 18 | 2023 | 49 | |
| 19 | 2007 | 46 | |
| 20 | 2022 | 42 |
About Hideya Kitamura
Hideya Kitamura is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Epidemiology, Genetics and Rheumatology, having authored 119 papers that have together received 3.3k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (63 papers), COVID-19 Clinical Research Studies (15 papers), Genetic Associations and Epidemiology (6 papers), Viral-associated cancers and disorders (4 papers), Systemic Sclerosis and Related Diseases (4 papers), Mycobacterium research and diagnosis (4 papers), Vasculitis and related conditions (3 papers) and Palliative Care and End-of-Life Issues (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Infectious Diseases (644 citations), Immunology and Allergy (72 citations), Genetics (417 citations) and Pathology and Forensic Medicine (126 citations). Hideya Kitamura has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Takashi Ogura, Tomohisa Baba, Eri Hagiwara, Tae Iwasawa, Tamiko Takemura, Akimasa Sekine, Koji Okudela, Satoshi Ikeda, Ryo Okuda and Hideaki Yamakawa. Their work appears in journals such as BMC Pulmonary Medicine, Scientific Reports, Respirology, Nature and Respiration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.